Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2014

View Archived Issues

Clinical study evaluates immunological response EMD-640744 in solid tumors

Shandong Xuanzhu Pharmaceutical Technology patents novel inhibitors for cancer

Mitsubishi Tanabe Pharma discloses new TRPM8 agonists for chronic pain

Meda and Valeant terminate joint ventures in Canada, Mexico and Australia

Santen and Oak Pharmaceuticals sign U.S. tafluprost licensing agreement

Pharmacokinetic bioequivalence of biosimilar GP-2017 and reference adalimumab

Lilly and Deciphera Pharmaceuticals present data on LY-3009120

Aptiom launched in the U.S. for use as adjunctive treatment of partial-onset seizures

Novel dendrimer-drug conjugates patented by Indian university

Mersana Therapeutics and Takeda to develop next-generation antibody-drug conjugates

IGM-55.5 potently binds and kills B cells in NHL patients

Soligenix receives SBIR grant award supporting phase II trial of SGX-942

JNJ-61186372 demonstrates activity for the treatment EGFR/c-Met-aberrant malignancies

Genentech and Array BioPharma reports ERK-1/2 inhibitor, GDC-0994

Abbott and AbbVie disclose new PDE10A inhibitors

Roche and Oryzon to develop epigenetics-based medicines

Pradaxa approved for deep venous thrombosis and pulmonary embolism

Merck & Co., Ferring and WHO to study room temperature-stable carbetocin for post-partum hemorrhage

Daiichi Sankyo extends European PREFER in AF registry

Cancer Genetics launches CALR mutation analysis test

Arno Therapeutics enrolls first patient in phase I/II onapristone trial in prostate cancer

Bristol-Myers Squibb submits daclatasvir and asunaprevir NDAs to FDA for HCV

Sun Pharmaceutical to acquire Ranbaxy Laboratories from Daiichi Sankyo

RedHill Biopharma to submit European MAA for RHB-102

Xenetic Biosciences reports phase I data for PulmoXen in cystic fibrosis

OncoSec Medical to relaunch phase II CTCL trial of ImmunoPulse DNA IL-12

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...